Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of Stock Options Warrants

The following table summarizes information about warrants granted during the years ended December 31,:

	2019				2018
	Number of warrants		Weighted Average Exercise Price		Number of warrants		Weighted Average Exercise Price
Balance, beginning of year		275,000	$	4.55		295,250	$	5.00
Warrants granted		891,667		7.00		50,000		9.72
Warrants expired		-		-		70,250		10.40
Warrants cancelled, forfeited		-		-		-		-
Warrants exercised		-		-		-		-
Balance, end of year		1,166,667		6.42		275,000		4.55
Exercisable warrants		1,166,667	$	6.42		275,000	$	4.55

Schedule of Outstanding Warrants

Outstanding warrants as of December 31, 2019 are as follows:

Range of Exercise Prices	Weighted Average residual life span (in years)		Outstanding Warrants		Weighted Average Exercise Price		Exercisable Warrants		Weighted Average Exercise Price
2.20		1.59		75,000	$	2.20		75,000	$	2.20
4.00		1.00		150,000		4.00		150,000		4.00
5.60		0.49		10,000		5.60		10,000		5.60
7.00		4.77		891,667		7.00		891,667		7.00
12.00		0.78		15,000		12.00		15,000		12.00
10.00		1.78		25,000		10.00		25,000		10.00
2.20 to 12.00		3.93		1,166,667	$	6.42		1,166,667	$	6.42

Schedule of Warrants Outstanding, Expiry Date and Exercise Prices

Warrants outstanding have the following expiry date and exercise prices as of the year ended December 31,:

Expiry Date	Exercise Prices		2019		2018
December 30, 2020	$	4.00		150,000		150,000
August 2, 2021		2.20		75,000		75,000
June 26, 2020		5.60		10,000		10,000
October 10, 2020		12.00		15,000		15,000
October 10, 2021		10.00		25,000		25,000
October 6, 2024		7.00		891,667		-
	$	6.42		1,166,667		275,000

Schedule of Stock Options Granted

Stock Options - The following table summarizes information about stock options granted during the years ended December 31, 2019 and 2018:

	2019				2018
	Number of stock options		Weighted Average Exercise Price		Number of stock options			Weighted Average Exercise Price
Balance, beginning of year		1,006,050	$	3.80		481,250		$	4.20
Stock options granted		127,500		5.00		592,000			3.40
Stock options expired		-		-		(1,800	)		-
Stock options cancelled, forfeited		-		-		(65,400	)		-
Stock options exercised		-		-		-			-
Balance, end of year		1,133,550		4.00		1,006,050			3.80
Exercisable stock options		952,425	$	3.94		792,050		$	3.80

Schedule of Outstanding Stock Options

Outstanding stock options as of December 31, 2019 are as follows:

Range of Exercise Prices	Weighted Average residual life span (in years)		Outstanding Stock Options		Weighted Average Exercise Price		Exercisable Stock Options		Weighted Average Exercise Price
1.50 to 1.80		2.13		114,050	$	1.70		114,050	$	1.70
2.20		1.59		175,000		2.20		175,000		2.20
5.00		3.58		127,500		5.00		31,875		5.00
10.00		4.89		125,000		10.00		125,000		10.00
2.40		3.18		340,000		2.40		297,500		2.40
4.40		3.84		108,250		4.40		81,188		4.40
5.40		3.92		143,750		5.40		127,813		5.40
0.075 to 0.50		3.22		1,133,550	$	4.00		952,425	$	3.94

Schedule of Stock Options, Expiry Date and Exercise Prices

Stock options outstanding at the end of the year have the following expiry date and exercise prices:

Expiry Date	Exercise Prices		December 31, 2019		December 31, 2018
August 2, 2021	$	2.20		175,000		175,000
February 17, 2022		1.70		114,050		114,050
March 05, 2023		2.40		340,000		340,000
July 31, 2023		5.00		127,500		-
October 31, 2023		4.40		108,250		108,250
November 30, 2023		5.40		143,750		143,750
November 20, 2024		10.00		125,000		125,000
	$	4.00		1,133,550		1,006,050

Summary of Stock Compensation Expense

The Company recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31, 2019 and 2018;

	2019		2018
In thousands
Stock compensation	$	388	$	569
Stock Option vesting		879		1,818
Total	$	1,267	$	2,387